Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Ferring bets on Gameto’s reproductive health solution through $1.38bn takeoverÂ
Gameto’s lead asset is a cell-based IVM tool, Fertilo, which is currently in late-stage development within the US.
Read Full Article
Pharma Tech
IDWeek 2026: despite missing primary endpoint, LB6V shows promise in Lyme disease
The commercial opportunity for a prophylactic Lyme disease vaccine in the US and Europe is substantial. LB6V is well placed to capitalise on this gap.
Read Full Article
Pharma Tech
Astellas fortifies immuno-oncology pipeline on $1.3bn Audax licensing dealÂ
Astellas pens this immuno-oncology deal with Audax as it looks to offset the upcoming patent expiry of key portfolio medicine, Xtandi.
Read Full Article
Pharma Tech
Anthropic plots IPO amid ongoing foray into drug developmentÂ
Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.
Read Full Article
Pharma Tech
FDA grants orphan drug status to Octant’s OCT-980 for RP
The FDA has granted orphan drug designation to Octant’s OCT-980, an investigational oral small molecule, to treat retinitis pigmentosa.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 29, 2026, 3:12 AM
Cancer care can be cheaper: 6 steps to cut drug costs
For innovator and sole-source drugs, negotiations should draw on the pilot's recommendation to assess clinical benefit and cost-effectiveness, ideally at national scale. Common price ceilings, contracts and specs would help remote hospitals procure medicines on the same terms as metropolitan ones.
Pharma Tech
Oct 28, 2026, 4:13 PM
Ferring bets on Gameto’s reproductive health solution through $1.38bn takeoverÂ
Gameto’s lead asset is a cell-based IVM tool, Fertilo, which is currently in late-stage development within the US.
Pharma Tech
Oct 28, 2026, 2:00 PM
IDWeek 2026: despite missing primary endpoint, LB6V shows promise in Lyme disease
The commercial opportunity for a prophylactic Lyme disease vaccine in the US and Europe is substantial. LB6V is well placed to capitalise on this gap.
PharmaShots
Oct 28, 2026, 12:03 PM
Cullinan Therapeutics Receives the US FDA’s IND Clearance for Velinotamig to Treat ITP and wAIHA
Shots: Cullinan Therapeutics has received IND clearance from the US FDA & clearance from Australia’s TGA to initiate a global P-Ib/IIa trial of velinotamig (CLN-803), a SC BCMAxCD3 T-cell engager, in adults with R/R immune thrombocytopenia (ITP) & warm autoimmune hemolytic anemia (wAIHA) The open-label, multicenter trial (NCT07738822) will evaluate a defined course of 4… The post Cullinan Therapeutics Receives the US FDA’s IND Clearance for Velinotamig to Treat ITP and wAIHA appeared first on PharmaShots.
PharmaShots
Oct 28, 2026, 12:00 PM
Arrowhead Receives the UK MHRA’s Approval and NICE Recommendation for Redemplo (Plozasiran) to Treat Familial Chylomicronaemia Syndrome
Shots: The UK MHRA has granted marketing authorisation to Arrowhead Pharmaceuticals’ Redemplo (plozasiran) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronaemia syndrome (FCS), diagnosed via genetic testing or clinical criteria NICE has also issued guidance recommending NHS funding in England & Wales for adults with genetically confirmed FCS whose response… The post Arrowhead Receives the UK MHRA’s Approval and NICE Recommendation for Redemplo (Plozasiran) to Treat Familial Chylomicronaemia Syndrome appeared first on PharmaShots.
PharmaShots
Oct 28, 2026, 11:49 AM
US WorldMeds Acquires Orbus Therapeutics to Advance Eflornithine in Adult Malignant Glioma
Shots: US WorldMeds has acquired Orbus Therapeutics, adding its late-stage oral eflornithine (DFMO) program for recurrent Grade 3 astrocytoma; Orbus is now a wholly owned subsidiary of US WorldMeds US WorldMeds made an undisclosed upfront payment, with Orbus eligible for development, regulatory & sales milestones, plus tiered royalties on US net sales The P-III (STELLAR)… The post US WorldMeds Acquires Orbus Therapeutics to Advance Eflornithine in Adult Malignant Glioma appeared first on PharmaShots.
News
Latest industry coverage
Google News
Oct 29, 2026, 4:16 AM
Biopharma cuts at manufacturing plants expected to affect 4,000+ - BioSpace
Biopharma cuts at manufacturing plants expected to affect 4,000+Â Â BioSpace
Google News
Oct 29, 2026, 4:07 AM
8 companies hiring in New York - BioSpace
8 companies hiring in New York  BioSpace
Google News
Oct 29, 2026, 4:01 AM
Korea’s First Homegrown Obesity Drug Begins Prescriptions, Challenging Mounjaro on Price - Businesskorea
Korea’s First Homegrown Obesity Drug Begins Prescriptions, Challenging Mounjaro on Price  Businesskorea
Google News
Oct 29, 2026, 3:26 AM
Biocon named among Science magazine’s best employers in global biotech and pharma for 2026 - Business Upturn
Biocon named among Science magazine’s best employers in global biotech and pharma for 2026  Business Upturn
Google News
Oct 29, 2026, 3:24 AM
Pharmaceutical Industry in Crisis: A Threat to Public Health - Pressenza - International Press Agency
Pharmaceutical Industry in Crisis: A Threat to Public Health  Pressenza - International Press Agency
Google News
Oct 29, 2026, 2:40 AM
How AI Generates Synthetic Patients to Solve Clinical Trial Recruitment Shortages - 36Kr
How AI Generates Synthetic Patients to Solve Clinical Trial Recruitment Shortages  36Kr
Google News
Oct 29, 2026, 1:18 AM
In a Twist, Venture-Backed Biotech Formation Bio Raises Its Own Investment Fund - WSJ
In a Twist, Venture-Backed Biotech Formation Bio Raises Its Own Investment Fund  WSJ
Google News
Oct 29, 2026, 12:41 AM
DRUGS AND BIOLOGICS—D.N.J.: Drugmaker loses cancer drug patent term extensions after missing statutory filing deadline by one day - VitalLaw.com
DRUGS AND BIOLOGICS—D.N.J.: Drugmaker loses cancer drug patent term extensions after missing statutory filing deadline by one day  VitalLaw.com
Google News
Oct 29, 2026, 12:07 AM
The Push for Injectable Peptides - Happi | Household And Personal Products Industry
The Push for Injectable Peptides  Happi | Household And Personal Products Industry
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer